Delhi Health Minister Dr Pankaj Kumar Singh convened a high-level review at the Delhi Secretariat on Monday to assess the capital’s preparedness following a rise in influenza cases, with particular attention to H1N1 infections, hospital capacity, medicines and testing arrangements.
What the review will cover
Officials from the Delhi Government, municipal corporations, medical officers and representatives from government hospitals were summoned for the meeting. The agenda, according to an official note, includes:
- assessment of hospital preparedness and bed availability;
- availability of medicines and essential medical equipment;
- readiness of government hospitals to manage a surge;
- testing, surveillance and reporting mechanisms for influenza cases.
The Health Minister sought to allay public concern, saying arrangements for beds, doctors, medicines and essential equipment are in place and that there is “no cause for panic.”
“There are adequate arrangements regarding beds, doctors, medicines and essential medical equipment in Delhi's hospitals. There is no cause for panic.”
Case numbers and trend
Health department figures show that on August 20 Delhi recorded 159 fresh influenza cases, of which 114 were identified as H1N1. Cumulative totals for 2026 stand at 1,777 H1N1 cases and 2,392 Influenza A cases. Influenza B cases in the year have reached 210, bringing the overall influenza tally to 2,602 so far in 2026.
| Category | 2026 cumulative |
|---|---|
| H1N1 cases | 1,777 |
| Influenza A (total) | 2,392 |
| Influenza B | 210 |
| All influenza | 2,602 |
ICMR assessment: no novel strain
Senior scientists at the Indian Council of Medical Research (ICMR) told a national laboratory update that the Influenza A (H1N1) pdm09 viruses presently detected in India align with the A/Missouri/11/2025 (H1N1) pdm09-like strain. The viruses are reported to belong to clade 6B.1A.5a2a, subclade D.3.1.1, which the agency said has been circulating since 2025.
ICMR emphasised that the current detections do not represent a new variant, but recommended focused vigilance for high‑risk groups and continued genomic and clinical surveillance.
Public-health implications and recommended actions
Health authorities plan to review capacity at tertiary and primary facilities to ensure that oxygen, antivirals where indicated, isolation areas and trained staff are available. The meeting’s emphasis on testing and surveillance aims to improve early detection and timely clinical management.
Public-health experts routinely advise that respiratory-severe cases, persons with comorbidities, the elderly and pregnant women should seek prompt medical attention if they develop influenza-like illness (fever with cough, sore throat, body aches or breathing difficulty). Routine preventive measures—hand hygiene, mask use in crowded or closed settings when symptomatic, and staying home when unwell—remain important.
Readers are reminded that this report is informational. For personalised medical advice, consult a qualified physician or local health authority.
What to watch next
- outcomes of the Delhi Health Department review and any directives for hospitals;
- whether testing and genomic surveillance identify further changes in circulating strains;
- any advisories on antiviral use or expanded vaccination drives for vulnerable populations.
The situation will be monitored as authorities update case counts and policy responses. ICMR’s assessment suggests the rise reflects circulation of an existing pdm09-like virus rather than emergence of a novel strain, but health administrators in the capital are proceeding with preparedness checks to ensure clinical systems are ready to respond.
